SCHEMBL21740357

SCHEMBL21740357

C[C@H]1CCN2C(=O)CC[C@@H]2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
KLK7 P49862 1/20 0.33
PARP1 P09874 1/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
DPP4 P27487 2/20 0.32
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
CHRNB2 P17787 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA7 P36544 1/20 0.30
CHRNA4 P43681 1/20 0.30
MAPK1 P28482 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM5 P08912 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19276941 1.00 RAB9A (0.34) RAB9ANPC1KLK7PARP1AKR1C3
SCHEMBL21739122 1.00 RAB9A (0.34) RAB9ANPC1KLK7PARP1AKR1C3
SCHEMBL17406830 0.89 CHRNB2 (0.38) RAB9ANPC1PARP1AKR1C3NOS3
SCHEMBL26053257 0.82 ALDH1A1 (0.35) RAB9ANPC1AKR1C3AKR1C2DPP4
SCHEMBL12279215 0.82 ALDH1A1 (0.35) RAB9ANPC1AKR1C3AKR1C2DPP4
SCHEMBL4331457 0.79 BRD4 (0.36) AKR1C3NOS3NOS1CHRNB2CHRNB4
SCHEMBL28508116 0.78 LMNA (0.37) RAB9ANPC1AKR1C3AKR1C2MEN1
SCHEMBL18319142 0.78 LMNA (0.37) RAB9ANPC1AKR1C3AKR1C2MEN1
SCHEMBL19277294 0.78 LMNA (0.37) RAB9ANPC1AKR1C3AKR1C2MEN1
SCHEMBL17185327 0.76 AKR1C3 (0.32) RAB9ANPC1AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020112872-A1 METHODS OF TREATING WHSC1-OVEREXPRESSING CANCERS BY INHIBITING SETD2 Epizyme, Inc. (US) 2020-06-04 WO disclosed
WO-2020037079-A1 SUBSTITUTED INDOLES AND METHODS OF USE THEREOF Epizyme, Inc. (US) 2020-02-20 WO disclosed